ESC Premium Access

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

Congress Presentation

About the speaker

Ms Caroline Sindet Clausen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

7 more presentations in this session

Association between sociodemographic factors and choice of Direct Oral Anticoagulants versus warfarin in atrial fibrillation: A population based cross-sectional study using Swedish Registers

Speaker: Mr G. Brobert (Solna, SE)

Thumbnail

Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis

Speaker: Doctor H. Yu (Seoul, KR)

Thumbnail

Non-vitamin K antagonist oral anticoagulants in comparison to phenprocoumon in a real-word setting of atrial fibrillation: an analysis of a large german health claims dataset

Speaker: Mr C. Hohmann (Cologne, DE)

Thumbnail

Dabigatran-induced esophagitis after radiofrequency catheter ablation

Speaker: Doctor Y. Ito (Tsukuba, JP)

Thumbnail

Epicardial application of amiodarone-releasing hydrogel: experimental study

Speaker: Professor O. Bockeria (Moscow, RU)

Thumbnail

Access the full session

Drug treatment in patients with arrhythmia

Speakers: Ms C. Clausen, Mr G. Brobert, Doctor H. Yu, Mr C. Hohmann, Doctor Y. Ito...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations